We recognize that there are many patients in need of a bone marrow donor that cannot participate in the PRESERVE I study due to its eligibility criteria or for logistical reasons. For these patients, it may feel like there is no hope. To serve these patients and further our company mission, we’ve launched the Ossium HOPE Program (HOPE Program + New HOPE). Through this program, we’re expanding access to our bone marrow product to patients outside of the PRESERVE I study.